Chimeric Antigen Receptor (CAR) T-cell therapy is a groundbreaking approach in cancer treatment that has revolutionized the oncology landscape. This innovative therapy involves genetically engineering patients’ T cells to express a CAR that targets cancer cells, leading to their destruction. The CAR T-cell therapy market has witnessed significant growth, with the market size valued at USD 2.5 […]
Tag: CAR T-Cell Therapy Market
Back To Top